WELLS FARGO & COMPANY/MN - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 114 filers reported holding ANAPTYSBIO INC in Q1 2023. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$273,692
-42.6%
15,239
-35.0%
0.00%
Q2 2023$476,566
+32.9%
23,430
+42.2%
0.00%
Q1 2023$358,605
+2658.5%
16,480
+2963.2%
0.00%
Q3 2022$13,000
-40.9%
538
-50.9%
0.00%
Q2 2022$22,000
-95.7%
1,096
-94.7%
0.00%
Q1 2022$514,000
-44.5%
20,790
-22.0%
0.00%
Q4 2021$926,000
-46.6%
26,649
-58.4%
0.00%
Q3 2021$1,735,000
-16.1%
63,984
-19.7%
0.00%
Q2 2021$2,067,000
+60.9%
79,701
+33.7%
0.00%
Q1 2021$1,285,000
+48.0%
59,624
+47.6%
0.00%
Q4 2020$868,000
+287.5%
40,402
+165.9%
0.00%
Q3 2020$224,000
-47.5%
15,196
-20.5%
0.00%
Q2 2020$427,000
+104.3%
19,123
+29.4%
0.00%
Q1 2020$209,000
-49.5%
14,777
-87.0%
0.00%
Q4 2019$414,000
-66.4%
113,676
+223.4%
0.00%
Q3 2019$1,231,000
-33.3%
35,153
+7.5%
0.00%
-100.0%
Q2 2019$1,845,000
-91.0%
32,702
-88.3%
0.00%
-83.3%
Q1 2019$20,495,000
+15.6%
280,570
+0.9%
0.01%0.0%
Q4 2018$17,736,000
-40.7%
278,015
-7.2%
0.01%
-25.0%
Q3 2018$29,904,000
+1048.4%
299,740
+717.6%
0.01%
+700.0%
Q2 2018$2,604,000
-31.1%
36,662
+1.0%
0.00%0.0%
Q1 2018$3,777,000
+59.0%
36,294
+53.8%
0.00%0.0%
Q4 2017$2,376,000
+828.1%
23,593
+222.0%
0.00%
Q3 2017$256,000
+181.3%
7,326
+92.3%
0.00%
Q2 2017$91,000
+2933.3%
3,810
+3710.0%
0.00%
Q1 2017$3,0001000.00%
Other shareholders
ANAPTYSBIO INC shareholders Q1 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,950,609$35,032,9384.94%
EcoR1 Capital, LLC 7,521,024$135,077,5914.56%
Saturn V Capital Management LP 577,101$10,364,7344.34%
GREAT POINT PARTNERS LLC 894,333$16,062,2212.93%
5AM Venture Management, LLC 357,733$6,424,8851.85%
First Light Asset Management, LLC 790,806$14,202,8761.35%
Boxer Capital, LLC 1,300,000$23,348,0001.24%
Frazier Life Sciences Management, L.P. 899,700$16,158,6121.07%
Deep Track Capital, LP 1,345,813$24,170,8010.93%
Palo Alto Investors LP 431,224$7,744,7830.73%
View complete list of ANAPTYSBIO INC shareholders